Skip to content

Application of radiofrequency ablation in hyperthyroidism

Application of radiofrequency ablation in hyperthyroidism

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056630
Enrollment
Unknown
Registered
2022-02-09
Start date
2022-02-10
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperthyroidism

Interventions

1:thermal ablation

Sponsors

Longyan City First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 51 cases were diagnosed as hyperthyroidism by clinical manifestation and laboratory examination; 2. And the thyroid gland is enlarged in degree III; 3. The course of disease = 5 years; 4. Recurrence after more than 2 years of standard anti-thyroid drug treatment; 5. The patient is unwilling to continue to receive anti-thyroid drugs or surgical treatment; 6. The patient and his family members were informed of the study and signed the consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal coagulation mechanism, severe bleeding tendency, severe agranulocytosis, and heart and lung function diseases that lead to intolerance of treatment; 2. Patients with thyroid malignant tumor; Patients with metal equipment such as cardiac pacemaker are placed in the body.

Design outcomes

Primary

MeasureTime frame
Thyroid volume;

Countries

china

Contacts

Public ContactXiuping Qiu

Longyan City First Hospital

594166189@qq.com+86 15806017513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026